Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +5.77% | +4.43% | -37.50% |
05-09 | Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.50% | 75.88M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Oppenheimer Adjusts Cue Biopharma's Price Target to $10 From $26, Maintains Outperform Rating